Our reference: <Journal code> <Item nr>

EL-v.3/2022<JOURNAL OWNER>

LICENSE AGREEMENT
PLEASE PROVIDE US WITH THE FOLLOWING INFORMATION, REVIEW OUR POLICIES AND THE LICENSE AGREEMENT, AND INDICATEYOUR ACCEPTANCE OF THE TERMS

Article entitled: <Item title>
Corresponding author: <title> <forename> <surname> [of au-type = corresponding]
To be published in the journal: <Journal title>
YOUR STATUS (PLEASE MARK ALL THAT APPLY)
I am the sole author of the manuscript
Please indicate which of the below also apply to you:
I am a UK, Canadian or Australian Government employee and Crown Copyright is asserted
I am a US Government employee and the Article is public domain and therefore the ‘License of publishing rights’ clause does not
apply
I am a contractor of the US Government under contract number: ……………….………………………….………………………
None of the above
I am one author signing on behalf of all co-authors of the manuscript
Please indicate which of the below also apply to you and your co-authors:
We are all US Government employees and the Article is public domain and therefore the ‘License of publishing rights’ clause does not
apply
I am a US Government employee but some of my co-authors are not
I am not a US Government employee but some of my co-authors are
The work was performed by contractors of the US Government under contract number: ...………………….…………..………...
All or some of the authors are UK, Canadian or Australian Government employees and Crown Copyright is asserted
Some of the authors are employees of the UK, Canadian or Australian Government but Crown Copyright is not asserted
None of the above
I am signing as an authorized representative and on behalf of my employer
Name and job title of licensee if different from corresponding author: .....................................................................................
Please indicate which of the below also apply to you:
The Article is authored by US Government employees and the Article is public domain and therefore the ‘License of publishing rights’clause does not apply
The work was performed by contractors of the US Government under contract number: ………………………………………..
The Article is authored by UK, Canadian or Australian Government employees and Crown Copyright is asserted
My employer is the owner of the copyright in the Article
Organization (please use the full name of the organization as it should appear in the copyright notice): ………………………………….
None of the above

Please tick one or more of the above boxes (as appropriate), review the License Agreement, and then sign and date the License Agreement in blackink.
Signed:Name printed:

Title and Company (if employer representative):
Date:
Please sign this License Agreement and return the completed and signed original of this form by mail or fax, or by e-mailing a scanned copy of thesigned original, retaining a copy for your files, to: Copyrights@elsevier.com

Our reference: <Journal code> <Item nr>

EL-v.3/2022

THE LICENSE AGREEMENT
License of publishing rights
I hereby grant to Journal Owner an exclusive publishing and distribution license in the manuscript identified above and any tables, illustrations orother material submitted for publication as part of the manuscript (the “Article”) in print, electronic and all other media (whether now known or later
developed), in any form, in all languages, throughout the world, for the full term of copyright, and the right to license others to do the same, effective
when the Article is accepted for publication. This license includes the right to enforce the rights granted hereunder against third parties.
Supplemental Materials“Supplemental Materials” shall mean materials published as a supplemental part of the Article, including but not limited to graphical, illustrative, video
and audio material.
With respect to any Supplemental Materials that I submit, Journal Owner shall have a perpetual worldwide, non-exclusive right and license to publish,extract, reformat, adapt, build upon, index, redistribute, link to and otherwise use all or any part of the Supplemental Materials, in all forms and media(whether now known or later developed) and permit others to do so.
.Research Data
“Research Data” shall mean the result of observations or experimentation that validate research findings and that are published separate to the Article,
which can include but are not limited to raw data, processed data, software, algorithms, protocols and methods.
With respect to any Research Data that I wish to make accessible on a site or through a service of Journal Owner, Journal Owner shall have a perpetualworldwide, non-exclusive right and license to publish, extract, reformat, adapt, build upon, index, redistribute, link to and otherwise use all or any partof the Research Data in all forms and media (whether now known or later developed), and permit others to do so. Where I have selected a specific end
user license under which the Research Data is to be made available on a site or through a service, the publisher shall apply that end user license to theResearch Data on that site or service.
Scholarly communication rights
I understand that I retain the copyright in the Article and that no rights in patents, trademarks or other intellectual property rights are transferred to theJournal. As the author of the Article, I understand that I shall have: (i) the same rights to reuse the Article as those allowed to third party users of theArticle under the CC-BY-NC-ND License, as well as (ii) the right to use the Article in a subsequent compilation of my works or to extend the Article
to book length form, to include the Article in a thesis or dissertation, or otherwise to use or re-use portions or excerpts in other works, for bothcommercial and non-commercial purposes. Except for such uses, I understand that the license of publishing rights I have granted to the Journal gives
the Journal the exclusive right to make or sub-license commercial use.
User rights
The publisher will apply the Creative Commons Attribution-Noncommercial-NoDerivative Works 4.0 International License (CC-BY-NC-ND) to theArticle where it publishes the Article in the journal on its online platforms on an Open Access basis. For further information, see
http://www.elsevier.com/about/open-access/open-access-options.
The CC-BY-NC-ND license allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not
permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal
publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work.
The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
Reversion of rights
Articles may sometimes be accepted for publication but later rejected in the publication process, even in some cases after public posting in “Articlesin Press” form, in which case all rights will revert to the author (see http://www.elsevier.com/locate/withdrawalpolicy).
Revisions and addenda
I understand that no revisions, additional terms or addenda to this License Agreement can be accepted without Journal Owner’s express written consent.
I understand that this License Agreement supersedes any previous agreements I have entered into with Journal Owner in relation to the Article fromthe date hereof.
Copyright Notice
The publisher shall publish and distribute the Article with the appropriate copyright notice.
Author Representations/Ethics and Disclosure
I affirm the Author Representations noted below and confirm that I have reviewed and complied with the relevant Instructions to Authors, Ethics inPublishing policy, Declarations of Interest disclosure, and information for authors from countries affected by sanctions. Please note that some journals
may require that all co-authors sign and submit Declarations of Interest disclosure forms. I am also aware of the publisher’s policies with respect toretractions and withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
For further information see the publishing ethics page at http://www.elsevier.com/publishingethics and the journal home page. For further information
on sanctions, see: https://www.elsevier.com/about/our-business/policies/trade-sanctions.
Author Representations•The Article I have submitted to the journal for review is original, has been written by the stated authors and has not been previously published.
•The Article was not submitted for review to another journal while under review by this journal and will not be submitted to any other journal.

Our reference: <Journal code> <Item nr>
EL-v.3/2022•The Article and the Supplemental Materials do not infringe any copyright, violate any other intellectual property, privacy or other rights ofany person or entity, or contain any libelous or other unlawful matter.
•I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited thesources in the Article or the Supplemental Materials.
•Except as expressly set out in this License Agreement, the Article is not subject to any prior rights or licenses•
If I and/or any of my co-authors reside in Russia, Belarus, Iran, Cuba or Syria the Article has been prepared in a personal, academic or
research capacity andnot as an official representative or otherwise on behalf of the relevant government or institution.
•If I am using any personal details or images of patients, research subjects or other individuals, I have obtained all consents required byapplicable law and complied with the publisher’s policies relating to the use of such images or personal information. See
http://www.elsevier.com/patientphotographs for further information.
•Any software contained in the Supplemental Materials is free from viruses, contaminants or worms.
•If the Article or any of the Supplemental Materials were prepared jointly with other authors, I have informed the co-author(s) of the termsof this License Agreement and that I am signing on their behalf as their agent, and I am authorized to do so.
For information on the publisher’s copyright and access policies, please see http://www.elsevier.com/copyright.
Governing Law and Jurisdiction
This License Agreement will be governed by and construed in accordance with the laws of the country or state of Journal Owner (“the GoverningState”), without regard to conflict of law principles, and the parties irrevocably consent to the exclusive jurisdiction of the courts of the Governing
State.